Cytotrait is a series a startup. 1 investor tracked. Status: possibledead.
Cytotrait is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cytotrait is a biotechnology company focused on developing advanced cell analysis technologies for research and clinical applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.